Loading...
ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenza
While most pathogens infect via mucosal surfaces, most current vaccines are delivered by injection. This situation remains despite awareness of the potential benefits of mucosal delivery for inducing protection against mucosa-infecting pathogens. A major obstacle to the development of such vaccines...
Na minha lista:
| Udgivet i: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514340/ https://ncbi.nlm.nih.gov/pubmed/25692970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/21645515.2014.990859 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|